UCLA researchers found administering a drug that harnesses the body’s immune system to brain cancer patients both before and after surgery could effectively treat recurrent cancer. Read more...
Photo: Patients who received an immunotherapy drug before and after surgery lived almost twice as long as patients who only received the drug after surgery. (Daily Bruin file photo)






